Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-10-01
Wentworth Timothy C Files Quest Diagnostics (DGX) Form 4 - October 01, 2026
Wentworth Timothy C reported holdings changes in DGX in this Form 4 filing, reported to the SEC on 2026-10-01.
- Insider
- Wentworth Timothy C
- Issuer
- Quest Diagnostics Inc. DGX · NYSE
- Filed
- Period
- 2026-10-01
- Accession
- 0001022079-26-000090
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| No transactions found | ||||||
About Quest Diagnostics Inc.
Quest Diagnostics Inc. is a leading provider of diagnostic information services, playing a crucial role in the healthcare sector. It is renowned for its extensive laboratory diagnostic services, which assist in diagnosing, monitoring, and managing medical conditions in both clinical and anatomic pathology. Quest Diagnostics serves healthcare providers, hospitals, health plans, employers, and government agencies, offering a broad array of tests that cover various medical needs, from routine blood tests to complex genetic testing. The company operates a vast network of laboratories and patient service centers across the United States, ensuring comprehensive and timely accessibility to diagnostic information. Quest Diagnostics is instrumental in advancing patient care by providing insights that help in early detection, diagnosis, and personalized treatment decisions. Furthermore, by leveraging cutting-edge technology, the company enhances healthcare management, catering to the increasing demand for precision medicine and personalized patient profiles. Quest Diagnostics' significant presence and commitment to innovation and quality place it at the forefront of diagnostic services, reflecting its critical influence in shaping modern healthcare practices and improving public health outcomes.
Track DGX insider activity
Get alerted when Quest Diagnostics Inc. executives buy or sell their shares.